Scientists Just Confirmed Gene Editing Repaired a Faulty Liver Gene Directly Inside a Human Patient!
Liver biopsy confirmed base editing corrected a disease-causing SERPINA1 mutation in a living human liver, offering stronger ...
Global market projected to expand from USD 8.94 billion in 2025 to USD 10.44 billion in 2026, registering an 18.1% CAGR ...
Nov 2 (Reuters) - Dutch gene therapy developer uniQure said on Monday the US FDA had accepted its application for its ...
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access have slowed their use.
Geek Spin on MSN
Gene therapy partially restores sight in blind patients
A gene treatment called optogenetic therapy has partly restored sight in legally blind patients, and a new study shows that the treatment appears to be safe, according to an international team of ...
A family affected by Sanfilippo syndrome raised millions of dollars for research. The Food and Drug Administration just ...
FDA final guidance sets a risk-based potency assurance roadmap for cell and gene therapies, spanning development, ...
Former biologics boss Peter Marks had a vision. With the FDA’s latest draft guidance, it’s coming to fruition. Speaking with BioSpace, current CBER leader Karim Mikhail said the “adapted pathway” is ...
Researchers have discovered a gene for a tandem potassium channel in an algal virus. The finding supports the view that giant ...
Much of what we know about biology comes from animal models, particularly mice. Applying these insights to humans, however, ...
Gene-drive technology, which could stop mosquitoes spreading malaria, is so far confined to laboratories. But as researchers ...
In a final guidance issued on Monday, the US Food and Drug Administration (FDA) laid out its expectations for cell and gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results